Clinical Trial Detail

NCT ID NCT02115828
Title A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

prostate cancer

Therapies

Vismodegib

Age Groups: adult

No variant requirements are available.